Introduction
About a hundred years ago an elderly physician and surgeon was busy in his laboratory in the College de France in Paris. He had become 72 years old on 8 April 1889 and wrote the following a little later: ' My general vigour, which had been considerable, has diminished notably and gradually during the last ten or twelve years. Before the experiments, which now occupy me, I had to sit down after standing for an hour working in the laboratory. After three or four hours, and sometimes after only two hours ofexperimental work in the laboratory, although I sat down, I was left exhausted ... Today and since the second day and above all the third day after the first injection, all that has changed and I have regained at least all the force that I possessed a number of years ago. Experimental work at the laboratory tires me little now ... I can now without difficulty, and even without thinking about it, go up and down stairs almostrunning, a thing which I always did before the age of sixty. By using the dynamometer I have established that there has been an incontestable increase in the force of my limbs'1.
The man in question was Charles-Edouard Brown-Sequard and the injection was of a watery extract of the testes of guinea-pigs and dogs. Almost immediately after his observations were reported at a meeting of the Societe de Biologie he was deluged with requests for testicular extract for the treatment of the elderly, and by the end of the year more than 12 000 physicians were using the 'Methode S&quardienne'..
Brown-Sequard believed that his extract contained an internal secretion important in the control of sexual behaviour, but the cynics were not persuaded, particularly when it was found that the treatment was not always successful and later discovered that the sex hormones of the testis were steroids not readily soluble in water, and thus unlikely to be present in significant amount in an aqueous extract of the testis. Critics also pointed to the likelihood of self-delusionof the placebo effect. But Brown-Sequard was aware of this possibility and tried to provide objective evidence concerning the efficacy of the treatment, such as by measuring his muscle strength.
Sex hormones and behaviour
The experiments of Brown-Sequard were carried out long before the sex hormones were identified, and with the extraction and purification of testosterone (from the urine of Berlin policemen) in the 1930s it might have been expected that the link between hormones and behaviour would quickly become well-defined; but this expectation has not been realized.
There is little doubt that sexual behaviour declines after castration in the male, but it is not necessarily lost. As Bancroft2 points out, in animals ejaculation is depressed first, then intromission and finally mounting, with restoration of these activities being produced in the reverse sequence by androgen. However, there is considerable variation from species to species, while the speed and extent of the depression in male sexual activity varies from individual to individual, and in some can be long sustained. Similar considerations apply to men. Married eunuchs were common in biblical times and there are many reports of the survival of normal sexuality in men after castration3'4, with Davidson et al.5 suggesting that between 10% and 63% of castrates retain a significant degree of sexual function.
The situation for the female is much more complex, for, despite the cyclical changes in the secretion of oestrogen and progesterone, there is remarkably little hard evidence in women for the occurrence of a peak in sexual activity close to ovulation, as occurs in the rodent, while loss of the ovaries does not necessarily lead to loss of libido. As far back as 1939, Pratt6 argued that subjective factors were of such importance that ovariectomized women could marry, exhibit normal libido and participate in satisfactory marital relations.
Few studies have as yet attempted to assess the role of subtle factors, such as the changes in sexual interest, or erotic imagery, in a quantitative fashion during the menstrual cycle, for work on the distribution of sexual activity during the menstrual cycle in women has commonly been based upon the occurrence ofcoitus, which is a joint activity and presumes that the interest of the male is constant. The application of assessments of mood and sexuality, such as those ofAdams et al.7, who concluded that there was a peak offemale-initiated behaviour around mid-cycle, or of Schreiner-Engel et al.', who measured vaginal blood flow in response to erotic stimuli at various stages of the menstrual cycle, remains somewhat novel.
Mood
Quite apart from their effects upon sexual behaviour, gonadal hormones affect mood. Often there are cyclic changes, which can be mimicked by treatment with oral contraceptives9, but the physiological basis of the shifts in mood remains uncertain and there are those who deny the existence ofthe constellation of changes collected under the heading of the 'premenstrual syndrome'10. Problems arise from a lack of comparability in the experimental methods employed. Among the methodological difficulties arising in the study of this condition are the use of women attending special clinics, who are therefore somewhat self-selected, and the highlighting of symptoms that are common among women and yet disregarded by many. There is also the Paper read to Section of Psychiatry, 13 May 1986 0141-0768/87/ 080499-02/$02.00/0 0 1987
The Royal Society of Medicine point that women who experience positive changes premenstrually, and show increased energy, drive and affection, have come to be ignored11.
The published figures on psychiatric ill-health, psychiatric treatment and psychiatric admissions suggest that women are more prone than men to negative affect symptoms, but the variations said to occur within the menstrual cycle in the rates of violence and motor accidents do not lead overall to a higher rate for women than for men. Further, the baseline from which variations can be gauged is illdefined, and the data could match suggestions of a mid-cycle syndrome of lowered crime, fewer epileptic seizures, increased self-esteem and elation, increased sexual desire and activity: it all depends upon the point of view.
Despite the reservations just outlined, the evidence against the existence of a premenstrual syndrome is not overwhelming, for when ovarian function was suppressed in women suffering from the syndrome, by treatment with a peptide serving to inhibit gonadotrophin secretion from the pituitary gland, there was unequivocal relief of the condition"2. The fact that this kind of 'medical ovariectomy' proved to be so beneficial points clearly to the involvement ofhormone secretion from the pituitary gland or ovaries in the causation of the condition, but the -reason for the therapeutic effect remains mysterious.
Neuropeptides and behaviour
An obvious possibility among the ways in which gonadal hormones could act to adjust behaviour is alteration in neurotransmitter function, although it is now evident that the term 'neurotransmitter' must be interpreted rather broadly in view of the peptide revolution, which was set in train by research on the physiology of the hypothalamic hypophysiotrophicreleasing factors and on the endogenous opiates".3
Very soon after the agents controlling the output of hormones from the pituitary gland, the releasing factors, were identified, study of their occurrence in the brain revealed that they could be found far away from the hypothalamus, and thus might have some other function.
These observations were the first ofmany pointing to the conclusion that peptides like the thyrotrophinreleasing factor, the first such compound studied in any detail, might well act as neurotransmitters. The importance of the idea that peptides of this nature might be involved in communication between nerve cells cannot be overestimated, for we now know that peptides can cause drinking, induce feelings of satiety, euphoria, and anxiety, and affect learning and memory'3, as well as possibly influencing sexual function. Thus, there is strong evidence that the hypothalamic gonadotrophin-releasing factor facilitates sexual behaviour in the rat'4, while the increased protein synthesis in nerve cells which is known to be brought about by oestrogen and progesterone could also point to the formation of peptides that in turn affect behaviour.
One reason for the waning of the sway exercised over neurological thought by the classical neurotransmitters, such as acetylcholine, noradrenaline, dopamine and serotonin, is the realization that the neurotransmitters are less efficient in influencing neural function than are the peptides. Neurotransmitters act at a concentration of 10-3 to 10-7mol/l, whereas other neuroeffector agents act in picomolar (10-12) concentrations or less. Schmitt'5 further argues that many such factors, called neuroinformational substances, can reach target neurons by diffusion through extracellular fluid. It is significant that receptors for many neuropeptides are to be found within the limbic system, the conglomerate of brain structures involved in much emotional behaviour. There are opiate receptors, as well as receptors for substance P, bombesin, cholecystokinin, neurotensin and insulin, to name but a few. The point here is that neuropeptides are obvious candidates as biochemical mediators of emotion. Pert et al.'6 wondered whether each neuropeptide biased or coloured informationprocessing uniquely when occupying its receptors in the brain and elsewhere, and whether the outcome might be a mood or drive peculiar to the neuropeptide. This idea was supported by recalling that opiates induce a state of intense pleasure, that substance P is associated with pain, angiotensin II with drinking, and cholecystokinin with satiety at the end of a meal. The idea of some neurochemical coding of behaviour beckons, and recalls older work with neurotransmitters, for the application of acetylcholine to the hypothalamus of the rat causes drinking, but treatment of the same locus with noradrenaline leads to eating. Similar antagonistic responses have emerged from the local chemical stimulation of the limbic system'7.
Just as mediaeval thinkers divided men into the sanguine, the bilious, the lymphatic and the nervous, so did the early endocrinological philosophers view individuals as thyroid-centred, adrenal-centred, gonad-centred, or pituitary-centred personalities ". Put oversimply, the next stage may be to regard the personality in terms of the prevailing balance between various peptides, with the endogenous opiates favouring the sanguine and corticotropinreleasing factor (CRF) excess possibly leading to a nervous or bilious outlook. To be specific, when CRF is applied directly to the brains of experimental animals, the peptide stimulates the locus ceruleus, which gives rise to most ofthe monoamines present in the brain considered to be involved in the causation of depression. It also causes excitation of the hypothalamo-pituitary-adrenal system to increase the blood level of adrenal steroids, and depresses eating and sexual behaviour. There may also be changes in activity and the induction ofelectrical seizures in the limbic system. This constellation of effects bears a strong resemblance to those seen in some cases of depression, and suggested to Gold and his associates'9 that an excessive secretion of CRF may generate some of the behavioural changes seen clinically in affective disease. They recalled that depressed subjects often show an increase in adrenal gland activity, significant anxiety (possibly mediated through the locus ceruleus), anorexia, diminished libido, and a change in the customary level of physical activity; and that they may respond to limbic system anticonvulsant therapy. There are thus many similarities between the behavioural changes seen in depression and those following from treatment with CRF. It is easy to see why the search is on for antagonists of CRF capable of passage across the bloodbrain barrier (and thus effective after intravenous administration) in order to assess the consequences of selective inhibition of CRF activity within the brain.
The immune system and hormone production The excitement generated over the new humours, the neurohumours, has tended to push the more familiar hormones to the side of the stage. Hormones were once regarded simply as the products of the pituitary gland, the adrenal and thyroid glands and the reproductive organs, plus some factors concerned with the control of digestion, and formed part of a distinct endocrine system. Now it is realized that hormones are produced by cells and tissues not commonly regarded as part of the endocrine system, such as the brain, or heart. Another example comes from the white blood cell population of the blood, where the lymphocytes are now considered to produce substances that are indistinguishable from hormones. This discovery may be of great significance in the understanding of the way in which psychogenic influences affect immunity and the resistance to disease, and merits some elaboration.
Peptides closely akin to, if not identical with, adrenocorticotrophic hormone (ACTH) and the endorphins occur in macrophage cells and lymphocytes of the immune system. These pro-opiomelanocortin-like (POMC) peptides and ACTH closely resemble one another in terms of antigenicity, molecular weight, bioactivity and in the suppression of their production by dexamethasone20, so that there is little doubt that one can substitute for the other in biological circumstances, although there is no suggestion that the immune system can fully replace the pituitary gland as a source of ACTH. Even so, the infection of hypophysectomized mice with Newcastle disease virus caused a time-dependent rise in corticosterone production that could be inhibited by treatment with dexamethasone, even though the main source of ACTH had been lost. The output of POMC-like peptides from lymphocytes can be increased by immunostimulants, such as viruses, tumour cells and bacterial lipopolysaccharide, as well as by hypothalamic-pituitary peptides, such as corticotrophin-releasing factor. Arginine vasopressin is less active in this respect, while the action of both peptides is blocked by the adrenal corticosteroid-like dexamethasone20. Again, these observations match those concerning the control of production of ACTH by the hypophysis.
Hormone production by the immune system is not limited to the POMC-derived peptides, but extends to immunoreactive thyrotrophin, vasoactive intestinal peptide and somatostatin21. There also appears to be the potential to produce chorionic gonadotrophin, growth hormone, follicle-stimulating hormone and luteinizing hormone. It could turn out that the lymphocytes respond to different stimuli in differing ways, for whilst T-cells release ACTH in response to Newcastle disease virus, they produce thyroidstimulating hormone in response to staphylococcal enterotoxin.
It must be evident that the impact of hormones upon behaviour occurs in ways that are only now achieving recognition. Besides assisting in the understanding of psychiatric disturbances, current advances are likely to provide new possibilities for therapeutic intervention. These are eagerly awaited.
